If you need more lookups,
subscriptions start at $34 USD/month.
Michael Steele Location
Richmond, VA, US
Michael Steele Work
2025 -now President and CEO @
2023 -2025 Principal @
2020 -2023 Vice President, Business Development Pharma Partnering @
2018 -2020 Vice President- Business Development @
now Vice President- Sales, Marketing and Business Development @
now Vice President- Corporate Business Development @
now Vice President @ Corautus Genetics, Inc. (acquired by Via Pharmaceuticals)
now Corporate Vice President- Business Development @ Life Therapeutics (acquired by Octapharma AG)
now Managing Director, Therapeutic Business Unit; Director, Corporate Business Development; others @ Serologicals Corp. (acquired by Millipore/Sigma)
Michael Steele Education
James Madison University - College of Business
MBA (Finance)
Vlerick Business School
James Madison University
Michael Steele Skills
Licensing
Mergers
Business Strategy
Corporate Development
Biotechnology
Diagnostics
Medical Devices
Life Sciences
Clinical Development
FDA
Infectious Diseases
Commercialization
Biopharmaceuticals
Lifesciences
Hardware Diagnostics
Mergers & Acquisitions
Business Development
Pharmaceutical Industry
Strategy
Technology Transfer
Medical Diagnostics
Molecular Diagnostics
Strategic Planning
Oncology
Cross Functional Team Leadership
u.s. Food and Drug Administration Fda
Product Launch
Point of Care
Marketing Strategy
Mergers and Acquisitions
u.s. Food and Drug Administration
Michael Steele Summary
Michael Steele, based in Richmond, VA, US, is currently a President and CEO at Activation Capital. Michael Steele brings experience from previous roles at The Steele Group, Biocartis, Essenlix Corporation and Chembio Diagnostic Systems, Inc.. Michael Steele holds a MBA in Finance @ James Madison University - College of Business. With a robust skill set that includes Licensing, Mergers, Business Strategy, Corporate Development, Biotechnology and more. Michael Steele has 3 emails on RocketReach.
Looking for a different Michael Steele?
Find contact details for 700 million professionals.